News
The final version of JA1 WP4 screening model is now available
We are pleased to present the final version of the JA1 WP4 screening model. The model enables production of structured HTA information which can be
The final version of HTA Core Model® and the Methodological Guidelines for Rapid REA of Pharmaceuticals is now available
We are very pleased to present the final version of HTA Core Model® and the Methodological Guidelines for Rapid Relative Effectiveness Assessment (REA) of Pharmaceuticals.
Ecorys report is now published
1 March 2013, Ecorys submitted the final draft report for an economic and governance analysis of the establishment of a permanent secretariat for the European
WP5 JA1 Pilot Pazopanib Report+Appendix
The final version of the WP5 JA1 pilot assessment using the draft model for Rapid Relative Effectiveness Assessment of Pharmaceuticals and guidelines. The joint assessment
Responses to Public consultation of the draft Project Plan on Endobarrier
The draft Project Plan on “Duodenal-jejunal bypass sleeve (Endobarrier®) for the treatment of obesity” was open to public consultation between 21 March and 4 April
Public consultation of the Methodological Guidelines for Rapid Relative Effectiveness Assessment of Pharmaceuticals
This document presents the public consultation of WP5 Joint Action Methodological Guidelines for Rapid Relative Effectiveness Assessment of Pharmaceuticals. The Methodological Guidelines for Rapid
Methodological guideline for REA of pharmaceuticals: Composite endpoints
This guideline provides a set of recommendations for the selection and assessment of clinical endpoints when completing a Relative Effectiveness Assessment (REA) of pharmaceuticals. A
Methodological guideline for REA of pharmaceuticals: Internal validity
This guideline focuses on the assessment of the risk of bias of randomized controlled trials (RCTs), the most relevant trials for relative effectiveness assessment (REA) of
Methodological guideline for REA of pharmaceuticals: Applicability of evidence in the context of a REA
This guideline provides a set of recommendations and aspects to be considered for the assessment of applicability in the context of a relative effectiveness assessment.
List of comments for the WP5 JA1 Pilot Pazopanib Report
The list of comments for the WP5 JA1 Pilot Pazopanib Report. The list provides the contact information of all the organisations that properly submitted their
